Autopsies on 614 members of a Kentucky community cohort who died between 2005 and 2024 identified 67 who had taken part in dementia trials. Only 10 to 29% had only the pathology their trial targeted, the lowest proportion in vascular cognitive impairment trials. On average each carried 2.54 coexisting brain pathologies, and they differed from the trial-naive only in slightly higher education.
Why it is interesting: Single-mechanism dementia trials were testing treatments in brains that mostly carried several pathologies at once.
Cite this item
BibTeX
Free sign-up. A digest of the new papers twice a week, grouped by domain.